#1 Clinical Trials Search in Europe

Dexibuprofen

Dexibuprofen, a non-steroidal anti-inflammatory drug (NSAID), has been the subject of several clinical trials to evaluate its safety and effectiveness in treating various conditions. These trials have explored its use in managing fever associated with respiratory tract infections, its safety profile in healthy volunteers, and its potential benefits for patients with osteoarthritis. This article summarizes the key findings from these clinical trials, providing insights into the potential applications of Dexibuprofen in medical treatment.

Table of Contents

What is Dexibuprofen?

Dexibuprofen is a medication that belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It is closely related to ibuprofen, a commonly used pain reliever and fever reducer[1]. Dexibuprofen is being studied for its potential benefits in treating various conditions, particularly those involving pain and inflammation.

Medical Conditions Treated

Based on the clinical trials data, Dexibuprofen is being investigated for the following medical conditions:

  • Fever due to common cold: Dexibuprofen syrup is being studied for its effectiveness in reducing fever associated with acute upper respiratory infections[1].
  • Osteoarthritis of the hip or knee: Researchers are evaluating Dexibuprofen’s potential in managing pain and other symptoms related to osteoarthritis, a condition characterized by joint pain and stiffness[4].

Dosage and Administration

Dexibuprofen is being studied in various forms and dosages:

  • Syrup form: For children with fever, dosages of 2.5 or 5 mg/kg and 3.5 or 7 mg/kg are being investigated[1].
  • Tablets: Adult dosages of 200 mg and 300 mg are being studied for safety and efficacy[2][3].
  • Powder for oral suspension: A 400 mg dose, taken twice daily (total daily dose of 800 mg), is being evaluated for osteoarthritis[4].

It’s important to note that these dosages are part of clinical trials and may not reflect final approved dosages. Always follow your healthcare provider’s instructions when taking any medication.

Safety and Efficacy

Several studies are focusing on evaluating the safety and efficacy of Dexibuprofen:

  • Fever reduction: One study is measuring the reduction in fever every hour for 3 hours, then again 3 days later, to assess the effectiveness of Dexibuprofen syrup[1].
  • Safety assessment: Researchers are monitoring for unwanted reactions, conducting clinical laboratory tests, and performing physical examinations to determine the safety profile of Dexibuprofen[1].
  • Adverse events: Studies are tracking the incidence and classification of adverse events following single and multiple dose administration[2][3].
  • Pharmacokinetics: Researchers are evaluating how the body processes Dexibuprofen by measuring parameters such as the time to reach maximum concentration (Tmax), maximum concentration (Cmax), area under the curve (AUC), and half-life (T1/2)[2][3].

Comparison with Ibuprofen

Several studies are directly comparing Dexibuprofen to Ibuprofen:

  • Fever treatment: One study is comparing the efficacy and safety of Dexibuprofen syrup to Ibuprofen syrup in treating fever associated with common cold[1].
  • Osteoarthritis treatment: Another study is comparing Dexibuprofen 400 mg powder for oral suspension to Ibuprofen 400 mg in patients with osteoarthritis of the hip or knee. This study aims to evaluate both the tolerability profile and overall efficacy of Dexibuprofen compared to Ibuprofen[4].

These comparisons will help determine if Dexibuprofen offers any advantages over the widely used Ibuprofen in terms of effectiveness or safety.

Ongoing Research

Current research on Dexibuprofen includes:

  • Fasting vs. Fed conditions: Studies are evaluating how food intake affects the safety and effectiveness of Dexibuprofen. This involves administering the drug to participants under both fasting and fed conditions[2][3].
  • Single vs. Multiple dose administration: Researchers are investigating the effects of both single and multiple doses of Dexibuprofen to understand its short-term and long-term impacts[2][3].
  • Large-scale efficacy study: A study involving 480 adult patients is underway to evaluate the tolerability and efficacy of Dexibuprofen in treating osteoarthritis of the hip or knee[4].

These ongoing studies will provide valuable information about the potential uses, effectiveness, and safety profile of Dexibuprofen, helping to determine its place in medical treatment.

Study Focus Condition Dosage Comparison Key Outcomes Measured
Fever reduction Respiratory tract infection 2.5-7 mg/kg syrup Ibuprofen syrup Temperature reduction, safety
Safety assessment Healthy volunteers 200 mg and 300 mg Fasting vs. Fed conditions Adverse events, pharmacokinetics
Osteoarthritis treatment Osteoarthritis of hip or knee 400 mg powder for oral suspension Ibuprofen 400 mg powder Tolerability, efficacy

FAQ

  • What conditions were studied in the Dexibuprofen clinical trials? The clinical trials studied Dexibuprofen for fever associated with respiratory tract infections, its safety in healthy volunteers, and its effectiveness in treating osteoarthritis of the hip or knee.
  • How was Dexibuprofen compared to other medications in the trials? In one trial, Dexibuprofen syrup was compared to Ibuprofen syrup for treating fever due to common cold. Another trial compared Dexibuprofen 400 mg powder to Ibuprofen 400 mg powder for osteoarthritis treatment.
  • What were the main objectives of the safety studies on Dexibuprofen? The safety studies aimed to evaluate the tolerability and safety of Dexibuprofen at different doses (200 mg and 300 mg) under fasting and fed conditions in healthy volunteers, assessing adverse events and pharmacokinetics.
  • How was the effectiveness of Dexibuprofen measured in the fever study? The effectiveness of Dexibuprofen in reducing fever was measured by recording temperature every hour for 3 hours and then once again 3 days later.
  • What was the focus of the osteoarthritis study involving Dexibuprofen? The osteoarthritis study focused on evaluating and comparing the tolerability profile and overall efficacy of Dexibuprofen 400 mg powder for oral suspension against Ibuprofen 400 mg in patients with painful osteoarthritis of the hip or knee.

Ongoing Clinical Trials on Dexibuprofen

  • Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Germany

Glossary

  • Dexibuprofen: A non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation.
  • Syrup: A liquid medication form, often used for easier administration, especially in children or those who have difficulty swallowing pills.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Osteoarthritis: A type of joint disease caused by breakdown of joint cartilage and underlying bone, often affecting the hip or knee.
  • Adverse events: Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Fasting condition: A state where a person has not eaten for a certain period, usually overnight, before taking a medication or undergoing a medical test.
  • Fed condition: A state where a person has eaten before taking a medication or undergoing a medical test.
  • Powder for oral suspension: A dry powder form of medication that is mixed with liquid before taking it by mouth.
  • Tolerability profile: The degree to which overt adverse effects of a drug can be tolerated by a patient.
  • Efficacy: The ability of a drug or medical treatment to produce a desired effect.

References

  1. https://clinicaltrials.gov/study/NCT00812422
  2. https://clinicaltrials.gov/study/NCT02956512
  3. https://clinicaltrials.gov/study/NCT02956525
  4. https://clinicaltrials.gov/study/NCT01066676